Arcutis Biotherapeutics director awarded equity grants
Arcutis Biotherapeutics director Christopher Peetz reported equity awards and holdings.
Rhea-AI Filing Summary
Arcutis Biotherapeutics director Christopher Peetz reported equity awards and holdings. On July 15, 2026 he received 4,315 RSUs, each convertible into one share upon vesting on the earlier of June 5, 2027 or immediately before the next annual stockholder meeting, subject to continued service.
He also received stock options for 21,486 and 13,010 shares at an exercise price of $27.78 per share, vesting over time as described and expiring July 15, 2036. An additional 187,500 shares are held indirectly by The Peetz Family Trust, for which he disclaims beneficial ownership beyond his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 38,811 shares
Grant/Award
4 txns
Insider
Peetz Christopher
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F3 | 21,486 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) F4 | 13,010 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 4,315 | $0.00 | $0.00 |
| holding | Common Stock F2 | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 34,496 contracts (Direct);
Common Stock — 4,315 shares (Direct);
Common Stock — 187,500 shares (Indirect, By The Peetz Family Trust)
Footnotes (4)
- F1. Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director of the Company. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of June 5, 2027, or immediately before the next annual meeting of stockholders, subject to the director's continued service through the vesting date.
- F2. Shares held by The Peetz Family Trust dated February 15, 2017, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
- F3. 1/3 each of the underlying shares subject to the option vest and become exercisable on the first annual anniversary of July 15, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the non-employee director's continued service through each applicable vesting date.
- F4. The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of June 5, 2027, or immediately before the next annual meeting of stockholders, subject to the director's continued service through the vesting date.
Key Figures
RSUs granted: 4,315 units
Stock options granted: 21,486 shares
Stock options granted: 13,010 shares
+5 more
8 metrics
RSUs granted
4,315 units
Restricted Stock Units granted July 15, 2026 for non-employee director service
Stock options granted
21,486 shares
Underlying common shares for one option grant dated July 15, 2026
Stock options granted
13,010 shares
Underlying common shares for second option grant dated July 15, 2026
Exercise price
$27.78 per share
Exercise price of stock options granted July 15, 2026
Option expiration
2036-07-15
Expiration date of the stock options granted to Christopher Peetz
Indirectly held shares
187,500 shares
Common shares held by The Peetz Family Trust
RSU vesting reference date
June 5, 2027
RSUs vest on the earlier of June 5, 2027 or immediately before the next annual meeting
Vesting commencement date
July 15, 2026
Vesting Commencement Date for the 21,486-share option grant
Key Terms
Restricted Stock Units ("RSUs"), pecuniary interest, Vesting Commencement Date, non-employee director
4 terms
Restricted Stock Units ("RSUs") financial
"Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
pecuniary interest regulatory
"disclaims beneficial ownership of such securities except to the extent of his pecuniary interest"
Vesting Commencement Date financial
"on the first annual anniversary of July 15, 2026 (the "Vesting Commencement Date")"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
non-employee director regulatory
"service as a non-employee director of the Company"
FAQ
What equity awards did Christopher Peetz report for ARQT on July 15, 2026?
Christopher Peetz reported 4,315 RSUs and stock options for 21,486 and 13,010 ARQT shares on July 15, 2026. The options carry a $27.78 exercise price per share and have specified multi-year vesting schedules tied to his non-employee director service.
How do the 4,315 RSUs granted to Christopher Peetz at ARQT vest?
The 4,315 RSUs vest into one ARQT share per unit on the earlier of June 5, 2027 or immediately before the next annual stockholder meeting. Vesting is conditioned on Christopher Peetz’s continued service as a non-employee director through the applicable vesting date.
What are the key terms of the stock options granted to Christopher Peetz at ARQT?
Christopher Peetz received stock options over 21,486 and 13,010 ARQT shares at a $27.78 exercise price, expiring July 15, 2036. One grant vests over four years from July 15, 2026, while the other vests 100% on the earlier of June 5, 2027 or the next annual meeting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
